Abstract
High-dose induction interferon alpha 2b + ribavirin improves initial treatment response on African-Americans in a prospective, randomized, controlled, multicenter trial in the VA population: Steven L Flamm, Lakeside VA, Chicago, IL; Charles Mendenhall, VA Hospital, Cincinnati, OH; David Johnson, VA Hospital, Phoenix, AZ; Maher Azzouz, VA Hospital Jackson, MS; Lawrence Lumeng, VA Hospital, Indianapolis, IN; Vivek Huilgol, VA Hospital, Shreveport,
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
